1-15 Drug court ensures that participants Program answer to Certification question #1 Yes from historically disadvantaged certification question Is there an attachment(s) to support this Not Currently 21 groups (based on race/ethnicity, requirement? Yes No Item Pending gender, sexual orientation/identity, of the attachment(s) Recommendation: disability, religion, socioeconomic Relevant Page Number(s) status) receive equal access, retention, treatment, dispositions, and incentives/sanctions) 1-16 Drug courts will follow Program answer to Certification question #2 Yes confidentiality laws/practices certification question Is there an attachment(s) to support this Not Currently 22 (described in Standards, Appendix D) Program policy and requirement? Yes No Item Pending procedure manual of the attachment(s) Recommendation: MOU Relevant Page Number(s) Client release form 1-18 Drug court information/records Program answer to Certification question #2 Yes remain confidential, except as certification question Is there an attachment(s) to support this Not Currently 23 authorized for disclosure (by state Program policy and requirement? Yes No Item Pending law, standards, for procedure manual Title(s) of the attachment(s) Recommendation: research/evaluation) as allowed by MOU Relevant Page Number(s) federal law (HIPAA, CFR 42 part 2) 1-19 Drug courts shall comply with federal Program answer to Certification question #2 Yes confidentiality laws (PHSA 42 USC certification question Is there an attachment(s) to support this Not Currently 24 290dd-2 and 290ee-3, and 42 CFR Program policy and requirement? Yes No Item Pending part 2) procedure manual Title(s) of the attachment(s) Recommendation: MOU Relevant Page Number(s)
1-15 21 Drug court ensures that participants from historically disadvantaged groups (based on race/ethnicity, gender, sexual orientation/identity, disability, religion, socioeconomic status) receive equal access, retention, treatment, dispositions, and incentives/sanctions) Program answer to certification question Certification question #1 Is there an attachment(s) to support this requirement? Yes No of the attachment(s) Relevant Page Number(s) Yes Not Currently Item Pending Recommendation: 1-16 22 Drug courts will follow confidentiality laws/practices (described in Standards, Appendix D) Program answer to certification question Program policy and procedure manual MOU Client release form Certification question #2 Is there an attachment(s) to support this requirement? Yes No of the attachment(s) Relevant Page Number(s) Yes Not Currently Item Pending Recommendation: 1-18 23 Drug court information/records remain confidential, except as authorized for disclosure (by state law, standards, for research/evaluation) as allowed by federal law (HIPAA, CFR 42 part 2) Program answer to certification question Program policy and procedure manual MOU Certification question #2 Is there an attachment(s) to support this requirement? Yes No Title(s) of the attachment(s) Relevant Page Number(s) Yes Not Currently Item Pending Recommendation: 1-19 24 Drug courts shall comply with federal confidentiality laws (PHSA 42 USC 290dd-2 and 290ee-3, and 42 CFR part 2) Program answer to certification question Program policy and procedure manual MOU Certification question #2 Is there an attachment(s) to support this requirement? Yes No Title(s) of the attachment(s) Relevant Page Number(s) Yes Not Currently Item Pending Recommendation:
NM_Certification_Checklist___revised_April_2018.docx